Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romney M Humphries

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
Journal of Clinical Microbiology|November 5, 2020
Performance of Antipseudomonal β-Lactams on the Accelerate PhenoTest BC Kit against a Collection of Pseudomonas aeruginosa IsolatesAaron Sikorski, Alena Shamsheyeva, Dulini Gamage, et al.
Journal of Clinical Microbiology|October 25, 2013
Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremiaCarmen L Giltner, Theodoros Kelesidis, Janet A Hindler, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection ModelJames M Kidd, Kamilia Abdelraouf, Tomefa E Asempa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2022
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2023
Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosaPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
Microbiology Spectrum|June 30, 2021
Identification and Antibiotic Susceptibility Patterns of Clinical Blood Culture Isolates Not Identified by a Rapid Microarray Diagnostic SystemJeffrey A Freiberg, Connor R Deri, Whitney J Nesbitt, et al.
Journal of Clinical Microbiology|December 9, 2016
Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensisIan H McHardy, Jennifer Veltman, Janet Hindler, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2018
Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapyPeera Hemarajata, Thomas Amick, Shangxin Yang, et al.
Journal of Clinical Microbiology|October 31, 2014
Performance of Etest and disk diffusion for detection of ciprofloxacin and levofloxacin resistance in Salmonella entericaEszter Deak, Janet A Hindler, Robert Skov, et al.
Journal of Clinical Microbiology|February 1, 2013
Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapyCarmen L Giltner, April M Bobenchik, Daniel Z Uslan, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Journal of Clinical Microbiology|November 5, 2020
Performance of Antipseudomonal β-Lactams on the Accelerate PhenoTest BC Kit against a Collection of Pseudomonas aeruginosa IsolatesAaron Sikorski, Alena Shamsheyeva, Dulini Gamage, et al.
Journal of Clinical Microbiology|October 25, 2013
Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremiaCarmen L Giltner, Theodoros Kelesidis, Janet A Hindler, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection ModelJames M Kidd, Kamilia Abdelraouf, Tomefa E Asempa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2022
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2023
Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosaPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
Microbiology Spectrum|June 30, 2021
Identification and Antibiotic Susceptibility Patterns of Clinical Blood Culture Isolates Not Identified by a Rapid Microarray Diagnostic SystemJeffrey A Freiberg, Connor R Deri, Whitney J Nesbitt, et al.
Journal of Clinical Microbiology|December 9, 2016
Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensisIan H McHardy, Jennifer Veltman, Janet Hindler, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2018
Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapyPeera Hemarajata, Thomas Amick, Shangxin Yang, et al.
Journal of Clinical Microbiology|October 31, 2014
Performance of Etest and disk diffusion for detection of ciprofloxacin and levofloxacin resistance in Salmonella entericaEszter Deak, Janet A Hindler, Robert Skov, et al.
Journal of Clinical Microbiology|February 1, 2013
Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapyCarmen L Giltner, April M Bobenchik, Daniel Z Uslan, et al.
Pageof 18